Browsing by Subject "Efficacy endpoints"
Now showing items 1-3 of 3
-
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
(Brac University, 2023-12)Researchers must prioritize non-small cell lung cancer clinical research due of its high mortality. Ongoing endeavors are being made to improve the accessibility, evaluation simplicity, and prediction accuracy of endpoints ... -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
(Brac University, 2023-01)Research is required in the area of non-small cell lung cancer, due to its widespread prevalence. Efforts to enhance the accessibility, evaluative simplicity, and prediction accuracy of endpoints in clinical trials are ... -
Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
(Brac University, 2024-05)Metastatic breast cancer requires more investigation because of its high incidence. Efforts to improve the accessibility, evaluative simplicity, and predictive accuracy of clinical trial endpoints are ongoing. In this ...
